Enteral nutritional therapy for induction of remission in Crohn's disease (Q24243037)

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Remission induced by an elemental diet in small bowel Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Review article: the role of nutrition in the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Accuracy of data in abstracts of published research articles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

The anti-inflammatory effects of enteral nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Experience with elemental diet in the treatment of inflammatory bowel disease. Is this primary therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Enteral nutritional therapy for inducing remission of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Polymeric Diet Alone Versus Corticosteroids in the Treatment of Active Pediatric Crohn’s Disease: A Randomized Controlled Open-Label Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

Dietary intake and nutritional treatment in childhood Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

Elemental diet as primary treatment of acute Crohn's disease: a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021

Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000542.PUB2

7 January 2021